Clinical Trial Update: Prognostic Value of Proadrenomedullin in Intra-abdominal Sepsis

View source ↗

Summary

Clinical trial update investigating whether proadrenomedullin can serve as a prognostic biomarker in intra-abdominal sepsis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intraabdominal Infections
• Intraabdominal Sepsis

Snippet

Sponsor: Instituto de Investigación Hospital Universitario La Paz | Conditions: Intraabdominal Infections | Status: UNKNOWN